Jiang Zhong Pharmaceutical's (SHA:600750) net profit increased to 306.7 million yuan in the first quarter from 288.9 million yuan in the year-ago period, according to a Monday filing by parent China Resources Pharmaceutical (HKG:3320) with the Hong Kong bourse.
Revenue at the drug company slipped to 1.18 billion yuan from 1.27 billion yuan a year earlier.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.